VREX vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

VREX

49.3
AI Score
VS
VREX Wins

PACB

43.3
AI Score

Investment Advisor Scores

VREX

49score
Recommendation
HOLD

PACB

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VREX PACB Winner
Revenue 636.10M 76.19M VREX
Net Income 9.90M -53.02M VREX
Gross Margin 34.4% 33.4% VREX
Net Margin 1.6% -69.6% VREX
Operating Income 52.60M -52.97M VREX
ROE 2.0% 159.6% PACB
ROA 0.9% -7.1% VREX
Total Assets 1.10B 751.85M VREX
Cash 99.20M 61.00M VREX
Current Ratio 3.38 4.92 PACB
Free Cash Flow -22.50M -84.87M VREX

Relative Price Performance (Last 90 Days)

VREX 1M: -0.1% · 3M: +71.9% PACB 1M: +92.4% · 3M: +53.0%

Current Technical Phase

VREX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.7% over 20 days), RSI 76

RSI (14): 76.2 · Price: $18.46

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 86

RSI (14): 86.4 · Price: $2.54

Fundamentals Snapshot

Metric VREX PACB
Market Cap — —
Forward P/E 17.3 -6.3
Trailing P/E 34.9 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% -1.1%
EPS 0.53 -0.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VREX is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.